No Data
No Data
Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
Express News | Watching Tonix Pharmaceuticals; Zacks Small-Cap Research Gives Stock $2.50 Price Valuation
Tonix Pharmaceuticals Appoints Raudabaugh, Gould as VPs
Tonix Pharmaceuticals Announces Expansion of Leadership Team With Two Strategic Hires
Tonix Pharma Talks NDA for Fibromyalgia Drug, FDA Decision on NDA Acceptance Expected December 2024 | NASDAQ:TNXP
WHO Extends Mpox Emergency; Canada Reports First Clade I Case